Solving stability and enabling new drug delivery options for next-generation Biologics is key to unlocking a vast potential. How could it work for your Biologic or mRNA project? Meet Ziccum CEO Ann Gidner and Chairman Fredrik Sjövall at BIO-Europe Spring, Barcelona Spain 16 – 18 March.
Ziccum will be represented at this premier industry event to share the company’s unique technology for cost efficiently formulating and drying liquid biologics as robust thermostable dry powders that require no cryogenic storage and are ideally suited for novel administration routes.
Book a meeting and discover the company’s excellent new mRNA/LNP results, generated in both internal and partnered projects.
Book a meeting here.
Read about Ziccum’s mRNA data and readouts here.